SCHEMBL5899460

SCHEMBL5899460

CCc1ccc(S(=O)(=O)NCC(=O)c2ccc(OC)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.61
ALDH1A1 P00352 7/20 0.58
GAA P10253 2/20 0.58
MEP1B Q16820 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
OPRK1 P41145 1/20 0.54
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
PKM P14618 1/20 0.51
KDM4E B2RXH2 1/20 0.51
NPC1 O15118 1/20 0.51
HPGD P15428 1/20 0.51
RAB9A P51151 1/20 0.51
LMNA P02545 1/20 0.51
HTT P42858 1/20 0.51
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899494 0.90 ALDH1A1 (0.59) TSHRALDH1A1GAAMEP1BSMN1; SMN2
SCHEMBL23014131 0.85 ALDH1A1 (0.57) TSHRALDH1A1MEP1BCA12CA1
SCHEMBL9777950 0.85 TSHR (0.59) TSHRALDH1A1MEP1BSMN1; SMN2NPC1
SCHEMBL5899469 0.83 ALDH1A1 (0.66) TSHRALDH1A1MEP1BSMN1; SMN2CA12
SCHEMBL23014374 0.83 MEP1B (0.54) TSHRALDH1A1GAAMEP1BSMN1; SMN2
SCHEMBL9778006 0.81 ALDH1A1 (0.67) ALDH1A1MEP1BCA1CA2PKM
SCHEMBL7637561 0.80 LMNA (0.63) ALDH1A1SMN1; SMN2CA1CA2NPC1
SCHEMBL5899545 0.79 CA1 (0.55) ALDH1A1CA12CA1CA2CA9
SCHEMBL20981395 0.78 TSHR (0.80) TSHRALDH1A1GAASMN1; SMN2OPRK1
SCHEMBL1278961 0.78 TSHR (0.80) TSHRALDH1A1GAASMN1; SMN2OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 TSHR 3445/4885ALDH1A1 139/4885GAA 2422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.